AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 172 filers reported holding AXSOME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $201,353 | -1.7% | 2,881 | +1.1% | 0.00% | 0.0% |
| Q2 2023 | $204,873 | +658.8% | 2,851 | +304.4% | 0.00% | – |
| Q2 2022 | $27,000 | -12.9% | 705 | -6.9% | 0.00% | – |
| Q1 2022 | $31,000 | +675.0% | 757 | +582.0% | 0.00% | – |
| Q4 2021 | $4,000 | +33.3% | 111 | +46.1% | 0.00% | – |
| Q3 2021 | $3,000 | -25.0% | 76 | +26.7% | 0.00% | – |
| Q2 2021 | $4,000 | +33.3% | 60 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | -40.0% | 60 | 0.0% | 0.00% | – |
| Q4 2020 | $5,000 | +25.0% | 60 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | -97.9% | 60 | -98.2% | 0.00% | -100.0% |
| Q1 2020 | $190,000 | -48.6% | 3,400 | -6.8% | 0.00% | -33.3% |
| Q4 2019 | $370,000 | – | 3,650 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
| MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
| Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
| WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
| Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
| RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
| MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
| Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
| Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |